175 related articles for article (PubMed ID: 15368105)
1. Neoplastic diseases of the papilla of Vater.
Kimura W; Futakawa N; Zhao B
J Hepatobiliary Pancreat Surg; 2004; 11(4):223-31. PubMed ID: 15368105
[TBL] [Abstract][Full Text] [Related]
2. p53 and p21/Waf1 protein expression and K-ras codon 12 mutation in carcinoma of the papilla of Vater.
Zhao B; Kimura W; Futakawa N; Muto T; Kubota K; Harihara Y; Takayama T; Makuuchi M
Am J Gastroenterol; 1999 Aug; 94(8):2128-34. PubMed ID: 10445539
[TBL] [Abstract][Full Text] [Related]
3. Differences in mucus and K-ras mutation in relation to phenotypes of tumors of the papilla of vater.
Matsubayashi H; Watanabe H; Yamaguchi T; Ajioka Y; Nishikura K; Kijima H; Saito T
Cancer; 1999 Aug; 86(4):596-607. PubMed ID: 10440687
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of carcinoma of the papilla of Vater.
Fischer HP; Zhou H
J Hepatobiliary Pancreat Surg; 2004; 11(5):301-9. PubMed ID: 15549428
[TBL] [Abstract][Full Text] [Related]
5. The clinicopathologic and immunohistochemical characteristics of ampulla of Vater carcinoma: the intestinal type is associated with a better prognosis.
Roh YH; Kim YH; Lee HW; Kim SJ; Roh MS; Jeong JS; Jung GJ
Hepatogastroenterology; 2007 Sep; 54(78):1641-4. PubMed ID: 18019683
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological characteristics and surgical procedures for carcinoma of the papilla of Vater.
Futakawa N; Kimura W; Wada Y; Muto T
Hepatogastroenterology; 1996; 43(7):260-7. PubMed ID: 8682475
[TBL] [Abstract][Full Text] [Related]
7. Total papillectomy for borderline malignant tumor of papilla of Vater.
Moriya T; Kimura W; Hirai I; Sakurai F; Isobe H; Ozawa K; Fuse A
Hepatogastroenterology; 2004; 51(57):859-61. PubMed ID: 15143934
[TBL] [Abstract][Full Text] [Related]
8. Endocrine cells in ampullary carcinoma.
Kamisawa T; Tu Y; Egawa N; Tsuruta K; Okamoto A; Funata N
J Hepatobiliary Pancreat Surg; 2009; 16(3):322-7. PubMed ID: 19214369
[TBL] [Abstract][Full Text] [Related]
9. Carcinoma of the ampulla of Vater associated with or without adenoma: a clinicopathologic analysis of 198 cases with reference to p53 and Ki-67 immunohistochemical expressions.
Takashima M; Ueki T; Nagai E; Yao T; Yamaguchi K; Tanaka M; Tsuneyoshi M
Mod Pathol; 2000 Dec; 13(12):1300-7. PubMed ID: 11144926
[TBL] [Abstract][Full Text] [Related]
10. Differing rates of loss of DPC4 expression and of p53 overexpression among carcinomas of the proximal and distal bile ducts.
Argani P; Shaukat A; Kaushal M; Wilentz RE; Su GH; Sohn TA; Yeo CJ; Cameron JL; Kern SE; Hruban RH
Cancer; 2001 Apr; 91(7):1332-41. PubMed ID: 11283934
[TBL] [Abstract][Full Text] [Related]
11. Prognosis of cancer of the duodenal papilla of Vater in relation to clinicopathological tumor extension.
Nakao A; Harada A; Nonami T; Kishimoto W; Takeda S; Ito K; Takagi H
Hepatogastroenterology; 1994 Feb; 41(1):73-8. PubMed ID: 8175122
[TBL] [Abstract][Full Text] [Related]
12. A collision tumor composed of cancers of the bile duct and ampulla of Vater--immunohistochemical analysis of a rare entity of double cancer.
Hirono S; Tani M; Terasawa H; Kawai M; Ina S; Uchiyama K; Nakamura Y; Kakudo K; Yamaue H
Hepatogastroenterology; 2008; 55(84):861-4. PubMed ID: 18705284
[TBL] [Abstract][Full Text] [Related]
13. Significant overexpression of SPARC/osteonectin mRNA in pancreatic cancer compared to cancer of the papilla of Vater.
Prenzel KL; Warnecke-Eberz U; Xi H; Brabender J; Baldus SE; Bollschweiler E; Gutschow CA; Hölscher AH; Schneider PM
Oncol Rep; 2006 May; 15(5):1397-401. PubMed ID: 16596217
[TBL] [Abstract][Full Text] [Related]
14. Expression of the caudal-type homeodomain transcription factors CDX 1/2 and outcome in carcinomas of the ampulla of Vater.
Hansel DE; Maitra A; Lin JW; Goggins M; Argani P; Yeo CJ; Piantadosi S; Leach SD; Biankin AV
J Clin Oncol; 2005 Mar; 23(9):1811-8. PubMed ID: 15774774
[TBL] [Abstract][Full Text] [Related]
15. Nodal involvement as an indicator of postoperative liver metastasis in carcinoma of the papilla of Vater.
Moriya T; Kimura W; Hirai I; Mizutani M; Ma J; Kamiga M; Fuse A
J Hepatobiliary Pancreat Surg; 2006; 13(6):549-55. PubMed ID: 17139430
[TBL] [Abstract][Full Text] [Related]
16. Carcinoma of the ampulla of Vater: comparative histologic/immunohistochemical classification and follow-up.
Zhou H; Schaefer N; Wolff M; Fischer HP
Am J Surg Pathol; 2004 Jul; 28(7):875-82. PubMed ID: 15223956
[TBL] [Abstract][Full Text] [Related]
17. Different clinicopathologic findings in two histologic types of carcinoma of papilla of Vater.
Kimura W; Futakawa N; Yamagata S; Wada Y; Kuroda A; Muto T; Esaki Y
Jpn J Cancer Res; 1994 Feb; 85(2):161-6. PubMed ID: 7511574
[TBL] [Abstract][Full Text] [Related]
18. K-ras mutation in adenomas and carcinomas of the ampulla of vater.
Howe JR; Klimstra DS; Cordon-Cardo C; Paty PB; Park PY; Brennan MF
Clin Cancer Res; 1997 Jan; 3(1):129-33. PubMed ID: 9815548
[TBL] [Abstract][Full Text] [Related]
19. Adenoma and tiny carcinoma in adenoma of the papilla of Vater--p53 and PCNA.
Sato T; Konishi K; Kimura H; Maeda K; Yabushita K; Tsuji M; Miwa A
Hepatogastroenterology; 1999; 46(27):1959-62. PubMed ID: 10430377
[TBL] [Abstract][Full Text] [Related]
20. p53 gene mutation and p53 protein overexpression in a patient with simultaneous double cancer of the gallbladder and bile duct associated with pancreaticobiliary maljunction.
Kasuya K; Nagakawa Y; Matsudo T; Ozawa T; Tsuchida A; Aoki T; Itoi T; Itokawa F
J Hepatobiliary Pancreat Surg; 2009; 16(3):376-81. PubMed ID: 19183832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
